What question did this study set out to answer?

This research aims to evaluate the risk of gastrointestinal diseases associated with severe α1-antitrypsin deficiency in individuals with PiZZ.

March 28, 2026Mayo Clinic Proceedings0 citationsOpen Access

Severe α1-Antitrypsin Deficiency and Increased Risk of Gastrointestinal Diseases

AHAdriana-Maria HillerLund University EPEeva PiitulainenLund University MEMagnus EkströmLund University

Key Points

This research aims to evaluate the risk of gastrointestinal diseases associated with severe α1-antitrypsin deficiency in individuals with PiZZ.
Comparative analysis of individuals with PiZZ and the general population
Assessment of gastrointestinal disease prevalence
Examination of specific conditions such as Crohn disease and ulcerative colitis.
Individuals with PiZZ have a higher incidence of gastrointestinal diseases compared to the general population.
Specific diseases include Crohn disease, ulcerative colitis, and diverticular disease.

Abstract

Individuals with PiZZ have an increased risk for development of gastrointestinal diseases (Crohn disease, ulcerative colitis, noninfectious gastroenteritis, and diverticular disease encompassing symptomatic diverticulosis and its complications), as compared with the general population.

Demander à l'IA

Bookmark

View Full Paper